LJAC
DGX icon

L.J. Altfest & Co’s Quest Diagnostics DGX Stock Holding History

L.J. Altfest & Co’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-18,644
Closed -$1.71M – 140
2016
Q4 		$1.71M Sell
18,644
-179
-1% -$15.4K 0.86% 28
2016
Q3 		$1.59M Buy
18,823
+51
+0.3% +$4.28K 1.06% 28
2016
Q2 		$1.53M Buy
18,772
+343
+2% +$26.1K 1.06% 34
2016
Q1 		$1.32M Sell
18,429
-126
-0.7% -$8.45K 1.36% 31
2015
Q4 		$1.32M Sell
18,555
-612
-3% -$41.1K 1.29% 33
2015
Q3 		$1.18M Buy
19,167
+102
+0.5% +$7.13K 1.16% 35
2015
Q2 		$1.38M Sell
19,065
-104
-0.5% -$7.68K 1.27% 35
2015
Q1 		$1.47M Buy
+19,169
New +$1.37M 1.37% 30

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

L.J. Altfest & Co's DGX Position: Q1 2017 in Review

L.J. Altfest & Co sold out of Quest Diagnostics (DGX) in Q1 2017, closing a stake of 18,644 shares — an estimated $1.71M sold.

L.J. Altfest & Co first reported a position in DGX in Q1 2015 and held it in 8 quarters. The position peaked at $1.71M in Q4 2016. 614 funds tracked by Wall St. Rank hold DGX as of Q1 2017.

  • L.J. Altfest & Co reported no remaining Quest Diagnostics position as of Q1 2017 after selling out during the quarter.
  • L.J. Altfest & Co sold 18,644 Quest Diagnostics shares in Q1 2017, an estimated $1.71M.
  • L.J. Altfest & Co first reported a position in Quest Diagnostics in Q1 2015 and held it in 8 quarters.
  • L.J. Altfest & Co's Quest Diagnostics position peaked at $1.71M in Q4 2016.
  • 614 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2017.

Based on L.J. Altfest & Co's 13F filing for Q1 2017, filed 3 May 2017.